![]() |
市场调查报告书
商品编码
1636724
2030 年动物饲料抗生素市场预测:按产品类型、配方、牲畜、销售管道和地区进行的全球分析Animal Feed Antibiotics Market Forecasts to 2030 - Global Analysis By Product Type, Formulation, Livestock, Sales Channel and By Geography |
根据 Stratistics MRC 的数据,2024 年全球动物饲料抗生素市值为 28.4 亿美元,预计到 2030 年将达到 41.1 亿美元,预测期内的复合年增长率为 6.3%。
动物饲料抗生素是添加到牲畜饲料中以预防疾病、促进生长和提高饲料效率的添加剂。透过控制细菌感染,这些抗生素有助于维持动物健康并提高产量。常用于家禽、猪和牛养殖业,以降低饲料生长比并优化营养吸收。
根据世界动物卫生组织(WOAH)2023年9月发布的报告,过去三年来,全球动物抗生素使用量下降了惊人的13%。
畜产品需求不断成长
全球对肉类、乳製品和蛋类等动物性食品的需求不断增长,是动物饲料抗生素市场的主要驱动力。这种需求是由人口成长、都市化和饮食偏好的变化所推动的。动物饲料中的抗生素透过预防疾病和提高饲料效率来改善牲畜的健康和生产力。随着畜牧业生产的扩大以满足日益增长的消费者蛋白质需求,饲料抗生素的使用对于维持牲畜健康和确保永续的生产系统至关重要。
对抗生素抗药性的担忧
人们对抗生素抗药性的担忧日益加剧,成为限制市场发展的一大因素。动物饲料中过度使用抗生素会导致抗生素抗药性细菌的产生,对人类和动物的健康构成威胁。为了缓解这个问题,世界各地的监管机构正在对抗生素的使用实施更严格的指导方针。这些规定迫使生产商探索益生菌和有机添加剂等替代品,但这些替代品可能不具成本效益或难以广泛使用,对市场成长构成挑战。
人们对牲畜健康的兴趣日益浓厚
对牲畜健康的日益关注为市场提供了巨大的成长机会。越来越多的农民开始采用先进的饲养解决方案来预防疾病和提高生产力。抗生素透过降低死亡率和提高整体效率在确保动物福利方面发挥着至关重要的作用。此外,生物技术的进步使得符合监管标准的特异性物种抗生素配方的开发成为可能,同时满足了消费者对安全、高品质畜产品日益增长的需求。
抗生素禁令
在一些地区,法规禁止使用抗生素作为生长促进剂,这对市场扩张构成了威胁。由于民众对抗生素抗药性的担忧,世界各国政府都在实施严格的政策,以遏制畜牧业中抗生素的滥用。这些法规迫使生产商寻求替代饲料添加剂,而这可能需要大量的研发投资。不遵守这些规定可能会导致处罚和消费者信心的丧失,进而进一步影响市场动态。
COVID-19 疫情扰乱了饲料抗生素市场的供应链,尤其影响了原料的供应和物流。然而,对作为农业本质的畜产品的需求仍在继续,对饲料抗生素的需求仍在继续,以保持牲畜的健康。疫情后的復原工作进一步促进了畜牧业活动,儘管面临暂时的挑战,但市场仍保持成长。
预计预测期内预混合料部分将实现最大幅度成长。
由于在动物饲料中持续使用抗生素的便利性和效率,预计预混合料将在预测期内占据最大的市场占有率。预混合料简化了饲料製备过程,同时确保活性成分均匀分布,改善动物健康和生产力。预混合料在家禽、猪和反刍动物养殖中的广泛应用证实了其在现代畜牧业管理系统中的重要性。
预计预测期内Fluoroquinolones的复合年增长率最高。
由于Fluoroquinolones抗生素对细菌感染有广泛的疗效,预计预测期内该类抗生素的复合年增长率将最高。这些抗生素对治疗牲畜的呼吸道和消化系统疾病非常有效,可以确保更好的健康结果。随着越来越多的农民将疾病预防和治疗放在首位以提高生产力,Fluoroquinolones抗生素作为一种可靠的解决方案正逐渐受到青睐。
由于北美地区拥有先进的畜牧养殖技术以及对动物健康管理的高度认识,预计在预测期内北美地区将占据最大的市场占有率。该地区强有力的法规结构确保负责任地使用抗生素,同时支持饲料解决方案的创新。此外,对优质肉类产品的需求不断增长,推动了家禽、猪和牲畜养殖业持续采用饲料抗生素。
由于人口快速成长、蛋白质消费量增加以及中国和印度等国家畜牧业活动的扩大,预计亚太地区将在预测期内实现最高成长率。政府推动永续农业和现代化农业方法的倡议进一步推动了对饲料抗生素的需求。该地区不断变化的饮食模式为市场扩张创造了巨大的机会。
According to Stratistics MRC, the Global Animal Feed Antibiotics Market is accounted for $2.84 billion in 2024 and is expected to reach $4.11 billion by 2030 growing at a CAGR of 6.3% during the forecast period. Animal feed antibiotics are additives incorporated into livestock feed to prevent diseases, promote growth, and enhance feed efficiency. By controlling bacterial infections, these antibiotics help maintain animal health and improve production yields. Commonly used in poultry, swine, and cattle industries, they reduce feed-to-growth ratios and optimize nutrient absorption.
According to a report released by the World Organisation for Animal Health (WOAH) on September 2023, global antimicrobial use in animals has indeed declined by 13% over the past three years.
Growing demand for livestock products
The rising global demand for animal-derived food products, including meat, dairy, and eggs, is a key driver for the animal feed antibiotics market. This demand is fueled by population growth, urbanization, and changing dietary preferences. Antibiotics in animal feed improve livestock health and productivity by preventing diseases and enhancing feed efficiency. As livestock farming expands to meet the increasing protein requirements of consumers, the use of feed antibiotics remains crucial for maintaining animal health and ensuring sustainable production systems.
Antibiotic resistance concerns
Growing concerns about antibiotic resistance act as a significant restraint for the market. The overuse of antibiotics in animal feed contributes to the development of antimicrobial-resistant bacteria, posing risks to human and animal health. Regulatory bodies worldwide are imposing stricter guidelines on antibiotic usage to mitigate this issue. These restrictions challenge market growth as producers must explore alternative solutions, such as probiotics or organic additives, which may not be as cost-effective or widely available.
Increased focus on animal health
The rising emphasis on livestock health presents a major growth opportunity for the market. Farmers are increasingly adopting advanced feed solutions to prevent diseases and enhance productivity. Antibiotics play a critical role in ensuring animal welfare by reducing mortality rates and improving overall efficiency. Additionally, advancements in biotechnology have enabled the development of species-specific antibiotic formulations that align with regulatory standards while addressing growing consumer demand for safe and high-quality animal products.
Regulatory bans on antibiotics
Regulatory bans on the use of antibiotics as growth promoters in several regions pose a threat to market expansion. Governments are implementing stringent policies to curb the misuse of antibiotics in livestock farming due to public health concerns over antimicrobial resistance. These regulations compel producers to seek alternative feed additives, which may require significant investment in research and development. Non-compliance with these regulations can lead to penalties and loss of consumer trust, further impacting market dynamics.
The COVID-19 pandemic disrupted supply chains in the animal feed antibiotics market, particularly affecting raw material availability and logistics. However, the essential nature of agriculture ensured continued demand for livestock products, driving the need for feed antibiotics to maintain animal health. Post-pandemic recovery efforts have further boosted livestock farming activities, sustaining market growth despite temporary challenges.
The premixes segment is expected to be the largest during the forecast period
The premixes segment is expected to account for the largest market share during the forecast period due to its convenience and efficiency in delivering consistent antibiotic dosages in animal feed. Premixes simplify feed preparation processes while ensuring uniform distribution of active ingredients, enhancing livestock health and productivity. Their widespread use across poultry, swine, and ruminant farming underlines their importance in modern livestock management systems.
The fluoroquinolones segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the fluoroquinolones segment is expected to witness the highest CAGR due to their broad-spectrum efficacy against bacterial infections. These antibiotics are highly effective in treating respiratory and gastrointestinal diseases in livestock, ensuring better health outcomes. As farmers increasingly prioritize disease prevention and treatment to optimize productivity, fluoroquinolones gain traction as a reliable solution.
The North America region is anticipated to account for the largest market share during the forecast period owing to its advanced livestock farming practices and high awareness about animal health management. The region's strong regulatory framework ensures responsible antibiotic usage while supporting innovation in feed solutions. Additionally, rising demand for high-quality meat products drives consistent adoption of feed antibiotics across poultry, swine, and cattle farming industries.
The Asia Pacific region is anticipated to register the highest growth rate over the forecast period due to rapid population growth, increasing protein consumption, and expanding livestock farming activities in countries like China and India. Government initiatives promoting sustainable agriculture and modern farming practices further boost demand for feed antibiotics. The region's evolving dietary patterns create significant opportunities for market expansion.
Key players in the market
Some of the key players in Animal Feed Antibiotics Market include Zoetis, Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, Cargill, Archer Daniels Midland (ADM), DSM, Nutreco, Kemin Industries, Adisseo, Alltech, Huvepharma, Vetoquinol, Ceva Sante Animale, Dechra Pharmaceuticals and Phibro Animal Health.
In November 2024, Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J. announced that the European Commission has granted the marketing authorization for BRAVECTO(R) TriUNO, a new formulation of BRAVECTO (fluralaner) for dogs that targets both internal and external parasites. The three-in-one chewable tablet will be available through licensed veterinarians. The product has also been approved by regulatory agencies in Peru, Guatemala, Nicaragua, and Costa Rica.
In April 2024, Zoetis Inc. and Phibro Animal Health Corporation announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis' medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
In October 2022, Huvepharma(R), Inc. is re-launching PoultrySulfa(R) (sulfamerazine, sulfamethazine and sulfaquinoxaline), the only FDA-approved triple-sulfa veterinary product available to the animal health market in the US. PoultrySulfa(R) is a water-soluble antibiotic powder that can be used as an aid in the control of coccidiosis and acute fowl cholera in chickens and turkeys when caused by pathogens susceptible to sulfamerazine, sulfamethazine and sulfaquinoxaline.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.